Abstract

BackgroundIn 2020, the American College of Rheumatology (ACR) presented an updated gout treatment guideline.[1]ObjectivesIn this report, we evaluated US rheumatologists’ stated adherence to and agreement with the 2020 ACR Guideline...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SAT0527 Gout Flare Prophylaxis Evaluated According to the 2012 American College of Rheumatology (ACR) Guidelines: Analysis from the Corrona Gout Registry
J.D Greenberg ... L.R Harrold
Annals of the Rheumatic Diseases | VOL. 73
J.D Greenberg, et. al.J.D Greenberg ... L.R Harrold
01 Jun 2014
Knowledge of and stated adherence to the 2020 ACR Guideline for Gout Management: Results of a survey of US rheumatologists.
Naomi Schlesinger ... Michael H Pillinger
The Journal of rheumatology | VOL. -
Naomi Schlesinger, et. al.Naomi Schlesinger ... Michael H Pillinger
15 Apr 2024
Hitting the target in gout.
The Lancet Rheumatology
The Lancet. Rheumatology | VOL. 2
The Lancet Rheumatology The Lancet Rheumatology
01 Jan 2020
AB1051 CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION OF UNCONTROLLED GOUT PRIOR TO PEGLOTICASE THERAPY
A Powers ... R Morlock
-
A Powers, et. al.A Powers ... R Morlock
23 May 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers